Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
European Urology Oncology
|
October 15, 2024
Minimal Residual Disease Detection with Urine-derived DNA Is Prognostic for Recurrence-free Survival in Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer Treated with Nadofaragene Firadenovec
Vikram M Narayan, Come Tholomier, Sharada Mokkapati, et al.
Journal of Clinical Medicine
|
October 14, 2022
Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of Intervention
Vincent T Bicocca, Kevin G Phillips, Daniel S Fischer, et al.
The Journal of Urology
|
May 20, 2026
Urine tumor DNA testing identifies recurrence and monitors therapy response in patients with high-risk non-muscle-invasive bladder cancer receiving intravesical bacillus Calmette-Guérin
Henning Bahlburg, Moritz Maas, Alberto Contreras-Sanz, et al.
Molecular Oncology
|
September 27, 2023
Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapy
Goran Rac, Hiten D Patel, Christopher James, et al.
European Urology
|
May 22, 2025
Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer
Marie-Pier St-Laurent, Parminder Singh, David J McConkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2023
Development and Multicenter Case-Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction
Keyan Salari, Debasish Sundi, Jason J Lee, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
European Urology Oncology
|
October 15, 2024
Minimal Residual Disease Detection with Urine-derived DNA Is Prognostic for Recurrence-free Survival in Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer Treated with Nadofaragene Firadenovec
Vikram M Narayan, Come Tholomier, Sharada Mokkapati, et al.
Journal of Clinical Medicine
|
October 14, 2022
Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of Intervention
Vincent T Bicocca, Kevin G Phillips, Daniel S Fischer, et al.
The Journal of Urology
|
May 20, 2026
Urine tumor DNA testing identifies recurrence and monitors therapy response in patients with high-risk non-muscle-invasive bladder cancer receiving intravesical bacillus Calmette-Guérin
Henning Bahlburg, Moritz Maas, Alberto Contreras-Sanz, et al.
Molecular Oncology
|
September 27, 2023
Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapy
Goran Rac, Hiten D Patel, Christopher James, et al.
European Urology
|
May 22, 2025
Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer
Marie-Pier St-Laurent, Parminder Singh, David J McConkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2023
Development and Multicenter Case-Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction
Keyan Salari, Debasish Sundi, Jason J Lee, et al.
Page
of 2